Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin and inflammatory biomarkers in acute deep vein thrombosis
2020-005467-31Phase 4Active
- Sponsor
- CHU Amiens-Picardie
- Start
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tinzaparin in deep vein thrombosis (DVT), sponsored by CHU Amiens-Picardie. Primary endpoint: CAM levels variation over time. Started Nov 2020; status: active.
02
Drugs
tinzaparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2020-005467-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005467-31.